US 11007270
Polymer-semaxanib moiety conjugates
granted A61KA61K31/404A61K47/545
Quick answer
US patent 11007270 (Polymer-semaxanib moiety conjugates) held by Nektar Therapeutics expires Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Nektar Therapeutics
- Grant date
- Tue May 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K31/404, A61K47/545, A61K47/60, A61P